"Economic Competition" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The effort of two or more parties to secure the business of a third party by offering, usually under fair or equitable rules of business practice, the most favorable terms.
| Descriptor ID |
D004465
|
| MeSH Number(s) |
N03.219.188
|
| Concept/Terms |
Economic Competition- Economic Competition
- Competition, Economic
- Competitions, Economic
- Economic Competitions
|
Below are MeSH descriptors whose meaning is more general than "Economic Competition".
Below are MeSH descriptors whose meaning is more specific than "Economic Competition".
This graph shows the total number of publications written about "Economic Competition" by people in this website by year, and whether "Economic Competition" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 4 | 6 | 10 |
| 2018 | 2 | 4 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Economic Competition" by people in Profiles.
-
Expedited Antitrust Review of COVID-19-Related Requests. Am J Law Med. 2021 07; 47(2-3):341-350.
-
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Value Health. 2021 05; 24(5):625-631.
-
Ambulatory Care Hastens Its Transformation into the Future. Front Health Serv Manage. 2020 Dec 01; 37(2):34-37.
-
The Personal Protective Equipment Crisis: To Save or to Build. Am J Public Health. 2020 08; 110(8):1165-1166.
-
Were it business opportunities or hidden risks: Observations on clinical trials and marketing authorizations of Gilead Science's remdesivir in China. Pharmazie. 2020 08 01; 75(8):407-410.
-
Being vulnerable. Elife. 2020 06 15; 9.
-
Prices For Cardiac Implant Devices May Be Up To Six Times Higher In The US Than In Some European Countries. Health Aff (Millwood). 2018 10; 37(10):1570-1577.
-
An Incomplete Prescription: President Trump's Plan to Address High Drug Prices. JAMA. 2018 06 19; 319(23):2373-2374.
-
A Method for Approximating Future Entry of Generic Drugs. Value Health. 2018 12; 21(12):1382-1389.
-
Delayed Generic Market Saturation After Patent Expiration-A Billion-Dollar Problem. JAMA Intern Med. 2018 05 01; 178(5):721-722.